Terracino v. Trimaco, Inc.

CourtDistrict Court, E.D. North Carolina
DecidedApril 29, 2024
Docket5:22-cv-00015
StatusUnknown

This text of Terracino v. Trimaco, Inc. (Terracino v. Trimaco, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Terracino v. Trimaco, Inc., (E.D.N.C. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NORTH CAROLINA WESTERN DIVISION

No. 5:22-CV-015-FL

ROBERT TERRACINO and ) BRADIE TERRACINO, ) ) ) ) Plaintiffs, )

) v. ) ORDER ) TRIMACO, INC., f/k/a/ TRIMACO, LLC; ) CHARLES COBAUGH; and DAVID C. ) MAY, ) ) Defendants. )

This patent case comes before the court pursuant to Markman v. Westview Instruments, Inc., 517 U.S. 370 (1996), for claim construction, with benefit of the parties’ written submissions, including their joint claim construction statement with proposed constructions of the disputed claim terms, claim construction briefs, and responses and replies thereto, and hearing thereon February 1, 2024. Also pending is plaintiffs’ motion to strike defendants’ supplement filed after claim construction hearing, expanding upon an opinion made reference to in argument. (DE 66). Rendered here is the court’s decision on the parties’ disputed claim terms and on plaintiffs’ motion to strike, which is denied. Issues bearing on the case schedule also are addressed. BACKGROUND Plaintiffs commenced this action January 1, 2022, and filed amended complaint April 18, 2022, seeking compensatory and punitive treble damages, and attorneys’ fees. (See DE 1, 17).1 Defendants moved to dismiss and for a more definite statement May 9, 2022. The court granted that motion in part and dismissed it in part, dismissing plaintiffs’ claims for fraudulent inducement, breach of contract, unconscionability, and violations of the Federal Defend Trade Secrets Act, 18

U.S.C. §§ 1831 et seq., and the North Carolina Unfair and Deceptive Trade Practices Act, N.C.G.S. §§ 75-1.1, et seq., and allowing plaintiffs’ claim for patent infringement to proceed. Plaintiffs assert that defendants, a company and its co-owners, have infringed their patent numbered 9,044,917 (“the ‘917 patent”). Plaintiffs’ patent describes a layered, high-friction drop cloth (“drop cloth”) that protects both painters, by minimizing the risk that they will lose their footing on uneven surfaces like stairs and airplane wings, and the floor or other surface on which the painters stand, by absorbing paint that might otherwise drip onto areas not meant to be painted. (See compl. ¶¶ 15-16). Plaintiffs’ invention is, in essence, a two-layered drop cloth with an absorbent canvas upper layer stitched to “a bumpy[,] sticky” lower layer. (Tr. (DE 64) at 10). The parties dispute the following claim terms: “a non-skid protective cloth or pad,

consisting of;” “adjacent;” “said downward projecting bumps comprising bumps having at least two different circumferential sizes;” “amorphous;” “said height of bumps having the smaller of said at least two different circumferential sizes being greater than said height of said larger of said at least two circumferential sizes;” “whereby when tested in accordance with TAPPI T548 specification, an average slide angle is no less than approximately 40 degrees;” and “whereby when said lower major surface of said single resilient layer is placed on a support surface, a Sliding

1 Hereinafter, references to the complaint (“compl.”) are to the operative first amended complaint at DE 17. Coefficient of friction measure in accordance with TAPPI T548 specification is greater than approximately 0.75.” (DE 47 at 2-4).

DISCUSSION At the onset, the court takes up the motion to strike, and following that, claim construction. Finally, the court addresses issues bearing on the case schedule below. A. Plaintiffs’ Motion to Strike The court accepted at hearing from plaintiffs a copy of U.S. Patent No. 10,683,607 B2, which lists defendant David C. May as an inventor and defendant Trimaco, Inc. as assignee, which had not been discussed in the parties’ briefs. (Tr. (DE 64) at 62-63). Defendants were given the opportunity to submit an addendum to their brief responsive to plaintiffs’ arguments regarding this patent, and they did so. Plaintiffs responded in accordance with direction given at hearing by the

court. (Id. at 68). Defendants responded again with a short answer to the court’s question at hearing regarding the procedural posture of a case from which its counsel quoted. (DE 65) (“The contested response”). Plaintiffs filed the instant motion to strike the contested response. Plaintiffs move to strike the contested response on the grounds that defendants had no right to file it. Rule 12(f) states that the court “may strike from a pleading an insufficient defense or any redundant, immaterial, impertinent, or scandalous matter.” Fed. R. Civ. P. 12(f). However, motions to strike are “generally viewed with disfavor because striking a portion of a pleading is a drastic remedy.” Waste Mgmt. Holdings, Inc. v. Gilmore, 252 F.3d 316, 347 (4th Cir. 2001). In addition, “district courts have the inherent authority to manage their dockets and courtrooms with

a view toward the efficient and expedient resolution of cases.” Dietz v. Bouldin, 579 U.S. 40, 47 (2016). At hearing, counsel for defendants quoted from Multilayer Stretch Cling Film Holdings, 831 F.3d at 1350, and the court asked counsel to confirm whether the quoted statement had been made in the context of claim construction. (See Tr. (DE 64) at 36-37). Counsel did not answer that question directly, but said that she “was going to check that for [the court] 100 percent,” in order to be sure. (Id.). Defendants submitted the contested response, which is about a page in

length, the day after a preliminary transcript appeared on the docket. Where the contested response was submitted in response to a question posed by the court at hearing, and in fulfilment of counsel’s promise to the court to answer that question, striking the response is not appropriate in this instance. Plaintiffs’ argument that the court allowed it at hearing to have “the last word” reads the court’s statement out of context. (Id. at 68). The court’s statement was made while setting a briefing schedule to address arguments “based on the Court's acceptance as Plaintiffs’ Exhibit 1 United States Patent Number 10,683,607 B2 dated June 16, 2020[.]” (Tr. (DE 64) at 68). Plaintiffs did have the last word on that issue, which is not addressed in the contested response. Accordingly,

plaintiffs’ motion is denied. B. Claim Construction 1. General Principles In Markman v. Westview Instruments, Inc., 52 F.3d 967 (Fed. Cir. 1995) (en banc), the Federal Circuit set forth the court’s role in determining as a matter of law the meaning and scope of patent claims, in the context of a patent infringement action, such as the one brought by plaintiffs here. Analysis of infringement involves two steps. “The first step is determining the meaning and scope of the patent claims asserted to be infringed.” Id. at 976.2 “The second step is comparing

2 Internal citations and quotation marks are omitted from all citations unless otherwise specified. the properly construed claims to the device accused of infringing.” Id. It is the first step, “commonly known as claim construction or interpretation,” that is at issue in the present order. Id. A patent is a written document in which an inventor makes “full disclosure of his invention to the [USPTO] and to the public,” for which, in return, the government confers “a property right to exclude anyone else from making, using, or selling the invention covered by [the patent] for

seventeen years.” Id. at 985. A patent is comprised of a “specification,” which includes (1) a description and (2) claims. 35 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Laryngeal Mask Co. Ltd. v. Ambu
618 F.3d 1367 (Federal Circuit, 2010)
Abbott Laboratories v. Sandoz, Inc.
566 F.3d 1282 (Federal Circuit, 2009)
PSN ILLINOIS, LLC v. Ivoclar Vivadent, Inc.
525 F.3d 1159 (Federal Circuit, 2008)
Bicon, Inc v. The Straumann Company
441 F.3d 945 (Federal Circuit, 2006)
Merck & Co. v. Teva Pharmaceuticals USA, Inc.
395 F.3d 1364 (Federal Circuit, 2005)
Wellman, Inc. v. Eastman Chemical Co.
642 F.3d 1355 (Federal Circuit, 2011)
3m Innovative Properties v. Tredegar Corporation
725 F.3d 1315 (Federal Circuit, 2013)
SkinMedica, Inc. v. Histogen Inc.
727 F.3d 1187 (Federal Circuit, 2013)
Baldwin Graphic Systems, Inc. v. Siebert, Inc.
512 F.3d 1338 (Federal Circuit, 2008)
Vederi, LLC v. Google, Inc.
744 F.3d 1376 (Federal Circuit, 2014)
Nautilus, Inc. v. Biosig Instruments, Inc.
134 S. Ct. 2120 (Supreme Court, 2014)
Ethicon Endo-Surgery, Inc. v. Covidien, Inc.
796 F.3d 1312 (Federal Circuit, 2015)
Dietz v. Bouldin
579 U.S. 40 (Supreme Court, 2016)
One-E-Way, Inc. v. International Trade Commission
859 F.3d 1059 (Federal Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Terracino v. Trimaco, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/terracino-v-trimaco-inc-nced-2024.